CoChat

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

Open access
Rajkumar, Vineeth S, Howell, Kevin, Csiszar, Katalin, Denton, Christopher P, Black, Carol M, Abraham, David J · 2005 · Arthritis Research & Therapy

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

The mechanisms by which microvascular damage leads to dermal fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) are unclear. We hypothesized that microvascular pericytes constitute a cellular link between microvascular damage and fibrosis by transdifferentiating into myofibroblasts. We used a combination of immunohistochemistry and double immunofluorescence labelling of frozen skin biopsies taken from normal and dcSSc patients to determine whether a phenotypic link between pericytes and myofibroblasts exists in dcSSc. Using α-smooth muscle actin, the ED-A splice variant of fibronectin (ED-A FN) and Thy-1 to identify myofibroblasts, we demonstrated the presence of myofibroblasts in fibrotic dcSSc skin. Myofibroblasts were totally absent from control skin, atrophic stage dcSSc skin and non-lesional skin. Using double immunofluorescence labelling, both myofibroblasts and pericytes were shown to express ED-A FN and Thy-1 in dcSSc skin but not in control skin. Proliferating cell nuclear antigen was also expressed by myofibroblasts and pericytes in dcSSc skin while being absent in control skin. These observations suggest that the presence of myofibroblasts may represent a transitional phase during the fibrotic stages of dcSSc and that Thy-1 +ve pericytes participate in the fibrogenic development of dcSSc by synthesizing ED-A FN, which may be associated with a proliferation and transition of pericytes and fibroblasts to myofibroblasts, thus linking microvascular damage and fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/ar1790

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Detection of myofibroblasts in dcSSc skin. Cryosections from (a) normal and (b-f) dcSSc skin were stained with an antibody against α-SMA. In normal skin, α-SMA staining was restricted primarily to microvascular pericytes enveloping capillaries ((a) arrows), sweat glands ((a) black arrowhead) and smooth muscle cells of erector pili muscles ((a) white arrowhead). In dcSSc samples, α-SMA-expressing myofibroblasts were detected in the dermis ((b,c,d) black arrows). Myofibroblasts were predominantly detected in the lower reticular dermis of SSc skin ((c,d) black arrows) while interstitial cells in the papillary dermis did not express α-SMA ((c,d) white arrows). In reticular dermal layers, α-SMA staining was also detected in the perivascular region ((c,d) black arrowheads) while in the papillary dermal layers α-SMA immunostaining was restricted to microvessels ((c) white arrowhead). In (e) non-lesional and (f) late stage dcSSc, the distribution of α-SMA was similar to that seen in normal skin. Original magnification (a,b,e,f) ×10, and (c,d) × 20. α-SMA, alpha smooth muscle actin; dcSSc, diffuse cutaneous systemic sclerosis.
Figure 1 Detection of myofibroblasts in dcSSc skin. Cryosections from (a) normal and (b-f) dcSSc skin were stained with an antibody against α-SMA. In normal skin, α-SMA staining was restricted primarily to microvascular pericytes enveloping capillaries ((a) arrows), sweat glands ((a) black arrowhead) and smooth muscle cells of erector pili muscles ((a) white arrowhead). In dcSSc samples, α-SMA-expressing myofibroblasts were detected in the dermis ((b,c,d) black arrows). Myofibroblasts were predominantly detected in the lower reticular dermis of SSc skin ((c,d) black arrows) while interstitial cells in the papillary dermis did not express α-SMA ((c,d) white arrows). In reticular dermal layers, α-SMA staining was also detected in the perivascular region ((c,d) black arrowheads) while in the papillary dermal layers α-SMA immunostaining was restricted to microvessels ((c) white arrowhead). In (e) non-lesional and (f) late stage dcSSc, the distribution of α-SMA was similar to that seen in normal skin. Original magnification (a,b,e,f) ×10, and (c,d) × 20. α-SMA, alpha smooth muscle actin; dcSSc, diffuse cutaneous systemic sclerosis.CC BY · PubMed Central
Figure 2 Increased expression of LOX and ED-A FN in dcSSc skin. Cryosections of (a,b) normal skin are compared with (c-f) dcSSc skin. In normal skin, immunostaining for LOX was detected in epidermal cells ((a) arrow). In dcSSc skin, immunostaining for LOX was detected in fibroblast-like cells throughout the dermis ((c,e) arrows) and in cells of the microvascular wall ((e) arrowhead). Little or no expression of ED-A FN was detectable in (b) normal skin, however, ED-A FN immunostaining was markedly increased in dcSSc skin ((d,f) arrows). Immunostaining for ED-A FN was also detected in cells of the microvascular wall ((f) arrowhead). Original magnification (a-d) × 10 and (e,f) × 20. dcSSc, diffuse cutaneous systemic sclerosis; ED-A FN, ED-A splice variant of fibronectin; LOX, lysyl oxidase.
Figure 2 Increased expression of LOX and ED-A FN in dcSSc skin. Cryosections of (a,b) normal skin are compared with (c-f) dcSSc skin. In normal skin, immunostaining for LOX was detected in epidermal cells ((a) arrow). In dcSSc skin, immunostaining for LOX was detected in fibroblast-like cells throughout the dermis ((c,e) arrows) and in cells of the microvascular wall ((e) arrowhead). Little or no expression of ED-A FN was detectable in (b) normal skin, however, ED-A FN immunostaining was markedly increased in dcSSc skin ((d,f) arrows). Immunostaining for ED-A FN was also detected in cells of the microvascular wall ((f) arrowhead). Original magnification (a-d) × 10 and (e,f) × 20. dcSSc, diffuse cutaneous systemic sclerosis; ED-A FN, ED-A splice variant of fibronectin; LOX, lysyl oxidase.CC BY · PubMed Central
Figure 3 Expression of ED-A correlates specifically with myofibroblasts in dcSSc skin. (a,c) Serial cryosections were stained with antibodies against ED-A FN and (b,d) α-SMA. Both ED-A FN ((a,c) arrows) and α-SMA+ve myofibroblasts ((b,d) arrows) were predominant in the lower reticular dermis of dcSSc skin. Note the absence of ED-A FN ((a) white arrow) and α-SMA+ve myofibroblasts ((b) white arrow) in the papillary dermis. In addition, immunostaining for ED-A FN was also detected in the wall of microvessels ((c) inset, arrowheads) correspondingly containing α-SMA-expressing pericytes ((d) inset, arrowheads). Original magnification (a,b) × 10, (c,d) × 20, inset (c,d) × 40. α-SMA, alpha smooth muscle actin; dcSSc, diffuse cutaneous systemic sclerosis; ED-A FN, ED-A splice variant of fibronectin.
Figure 3 Expression of ED-A correlates specifically with myofibroblasts in dcSSc skin. (a,c) Serial cryosections were stained with antibodies against ED-A FN and (b,d) α-SMA. Both ED-A FN ((a,c) arrows) and α-SMA+ve myofibroblasts ((b,d) arrows) were predominant in the lower reticular dermis of dcSSc skin. Note the absence of ED-A FN ((a) white arrow) and α-SMA+ve myofibroblasts ((b) white arrow) in the papillary dermis. In addition, immunostaining for ED-A FN was also detected in the wall of microvessels ((c) inset, arrowheads) correspondingly containing α-SMA-expressing pericytes ((d) inset, arrowheads). Original magnification (a,b) × 10, (c,d) × 20, inset (c,d) × 40. α-SMA, alpha smooth muscle actin; dcSSc, diffuse cutaneous systemic sclerosis; ED-A FN, ED-A splice variant of fibronectin.CC BY · PubMed Central
Figure 4 Expression of Thy-1 is increased in dcSSc skin. Cryosections from (a,b) normal and (c,d) dcSSc were stained for Thy-1 expression. In normal skin, immunostaining for Thy-1 was predominantly located within the microvascular wall and immediate perivascular region ((a,b) arrows). Thy-1 staining of interstitial fibroblasts was also detected ((b) arrowhead). In dcSSc skin, immunostaining of fibroblastic cells was considerably more pronounced throughout the interstitial dermis ((c) arrows) while perivascular immunostaining in dcSSc skin ((d) arrow) was less pronounced than that observed in normal skin ((b) arrow). dcSSc, diffuse cutaneous systemic sclerosis.
Figure 4 Expression of Thy-1 is increased in dcSSc skin. Cryosections from (a,b) normal and (c,d) dcSSc were stained for Thy-1 expression. In normal skin, immunostaining for Thy-1 was predominantly located within the microvascular wall and immediate perivascular region ((a,b) arrows). Thy-1 staining of interstitial fibroblasts was also detected ((b) arrowhead). In dcSSc skin, immunostaining of fibroblastic cells was considerably more pronounced throughout the interstitial dermis ((c) arrows) while perivascular immunostaining in dcSSc skin ((d) arrow) was less pronounced than that observed in normal skin ((b) arrow). dcSSc, diffuse cutaneous systemic sclerosis.CC BY · PubMed Central
Figure 5 Double immunofluorescence labelling of normal and dcSSc skin biopsies. Cryosections from (a,c) normal and (b,d) dcSSc were double stained for endothelial cells using (a,b) PAL-E antibody and Thy-1 and (c,d) α-SMA and Thy-1. Thy-1 is labelled with FITC while PAL-E and α-SMA are labelled with Texas Red. In both (a) normal and (b) dcSSc, immunofluorescence for Thy-1 ((a,b) arrow, green colour) and PAL-E ((a,b) arrowhead, red colour) was consistently exclusive and showed no colocalization. In both (c) normal and (d) dcSSc, strong colocalization between Thy-1 and α-SMA was evident ((c,d) arrows, yellow colour). In normal skin, Thy-1 immunofluorescence that did not colocalize with α-SMA was observed immediately adjacent to microvessels ((c) arrowheads, green colour). Cryosections from dcSSc were double stained for (e,f,g) ED-A FN and α-SMA and (h) ED-A FN and Thy-1. ED-A FN is labelled with Texas Red while α-SMA and Thy-1 are labelled with FITC. Cell nuclei are counterstained blue with DAPI. Colocalization between α-SMA and ED-A FN was detected in dermal fibroblastic cells ((e) arrows, yellow colour) as well as in the microvascular wall ((f,g) arrows, yellow colour). Colocalization was also observed between ED-A FN and Thy-1 in both the microvascular wall ((h) arrow, yellow colour) and in dermal fibroblastic cells ((h) arrowheads, yellow colour). Original magnification (a-d,h) × 10, (e,f) × 20, (g) × 40. α-SMA, alpha smooth muscle actin; DAPI, 4,6-diamidino-2-phenylindole; dcSSc, diffuse cutaneous systemic sclerosis; ED-A FN, ED-A splice variant of fibronectin; FITC, fluorescein isothiocyanate.
Figure 5 Double immunofluorescence labelling of normal and dcSSc skin biopsies. Cryosections from (a,c) normal and (b,d) dcSSc were double stained for endothelial cells using (a,b) PAL-E antibody and Thy-1 and (c,d) α-SMA and Thy-1. Thy-1 is labelled with FITC while PAL-E and α-SMA are labelled with Texas Red. In both (a) normal and (b) dcSSc, immunofluorescence for Thy-1 ((a,b) arrow, green colour) and PAL-E ((a,b) arrowhead, red colour) was consistently exclusive and showed no colocalization. In both (c) normal and (d) dcSSc, strong colocalization between Thy-1 and α-SMA was evident ((c,d) arrows, yellow colour). In normal skin, Thy-1 immunofluorescence that did not colocalize with α-SMA was observed immediately adjacent to microvessels ((c) arrowheads, green colour). Cryosections from dcSSc were double stained for (e,f,g) ED-A FN and α-SMA and (h) ED-A FN and Thy-1. ED-A FN is labelled with Texas Red while α-SMA and Thy-1 are labelled with FITC. Cell nuclei are counterstained blue with DAPI. Colocalization between α-SMA and ED-A FN was detected in dermal fibroblastic cells ((e) arrows, yellow colour) as well as in the microvascular wall ((f,g) arrows, yellow colour). Colocalization was also observed between ED-A FN and Thy-1 in both the microvascular wall ((h) arrow, yellow colour) and in dermal fibroblastic cells ((h) arrowheads, yellow colour). Original magnification (a-d,h) × 10, (e,f) × 20, (g) × 40. α-SMA, alpha smooth muscle actin; DAPI, 4,6-diamidino-2-phenylindole; dcSSc, diffuse cutaneous systemic sclerosis; ED-A FN, ED-A splice variant of fibronectin; FITC, fluorescein isothiocyanate.CC BY · PubMed Central
Figure 6 Distribution of proliferating cells in normal and dcSSc skin. Cryosections from (a) normal and (b,c) dcSSc were stained with an anti-PCNA antibody. In normal skin, PCNA immunostaining was restricted to cells within the epidermis and sweat glands ((a,b) arrows). In two out of ten dcSSc samples, PCNA was detected in fibroblastic cells ((b) arrows) and in microvessels ((c) arrows). Double immunofluorescence labelling of dcSSc skin: cryosections were double stained with a combination of antibodies against (d,e) PCNA and α-SMA and (f) PCNA and PAL-E. PCNA is labelled with Texas Red while α-SMA and PAL-E are labelled with FITC. Colocalization was detected with PCNA and α-SMA antibodies within the microvasculature ((d,e) arrows, yellow colour). When used in combination with PAL-E, PCNA-labelled cells ((f) arrows) were predominantly located adjacent and abluminal to endothelial cells ((f) arrowheads). Original magnification × 20. α-SMA, alpha smooth muscle actin; dcSSc, diffuse cutaneous systemic sclerosis; PCNA, proliferating cell nuclear antigen; FITC, fluorescein isothiocyanate.
Figure 6 Distribution of proliferating cells in normal and dcSSc skin. Cryosections from (a) normal and (b,c) dcSSc were stained with an anti-PCNA antibody. In normal skin, PCNA immunostaining was restricted to cells within the epidermis and sweat glands ((a,b) arrows). In two out of ten dcSSc samples, PCNA was detected in fibroblastic cells ((b) arrows) and in microvessels ((c) arrows). Double immunofluorescence labelling of dcSSc skin: cryosections were double stained with a combination of antibodies against (d,e) PCNA and α-SMA and (f) PCNA and PAL-E. PCNA is labelled with Texas Red while α-SMA and PAL-E are labelled with FITC. Colocalization was detected with PCNA and α-SMA antibodies within the microvasculature ((d,e) arrows, yellow colour). When used in combination with PAL-E, PCNA-labelled cells ((f) arrows) were predominantly located adjacent and abluminal to endothelial cells ((f) arrowheads). Original magnification × 20. α-SMA, alpha smooth muscle actin; dcSSc, diffuse cutaneous systemic sclerosis; PCNA, proliferating cell nuclear antigen; FITC, fluorescein isothiocyanate.CC BY · PubMed Central
Figure 7 Nailfold capillaroscopy of (a) normal and (b,c) dcSSc patients. In the active pattern of capillary damage, frequent giant capillaries are present ((b) arrow) accompanied by moderate capillary loss and disorganisation of capillary architecture. Late disease pattern was characterized by severe capillary disorganisation with loss of capillaries ((c) arrow). Magnification ×150. dcSSc, diffuse cutaneous systemic sclerosis.
Figure 7 Nailfold capillaroscopy of (a) normal and (b,c) dcSSc patients. In the active pattern of capillary damage, frequent giant capillaries are present ((b) arrow) accompanied by moderate capillary loss and disorganisation of capillary architecture. Late disease pattern was characterized by severe capillary disorganisation with loss of capillaries ((c) arrow). Magnification ×150. dcSSc, diffuse cutaneous systemic sclerosis.CC BY · PubMed Central
Figure 8 Convergence of microvascular pericytes and resident fibroblasts to a myofibroblast lineage in SSc. Two pathways potentially contribute to the fibrogenic response in dcSSc. Microvascular pericytes (Thy-1+ve /α-SMA+ve ) become activated as a result of microvascular damage and produce the ED-A splice variant of fibronectin, a protein known to induce the myofibroblast phenotype. The microvascular derived ED-A FN in concert with the actions TGF-β may also act upon resident perivascular fibroblasts (Thy-1+ve /α-SMA-ve ) stimulating their differentiation to myofibroblasts. Proliferation of both pericytes and fibroblasts may help to create a pool of potential myofibroblasts. α-SMA, alpha smooth muscle actin; dcSSc, diffuse cutaneous systemic sclerosis; ED-A FN, ED-A splice variant of fibronectin; TGF-β, transforming growth factor-beta.
Figure 8 Convergence of microvascular pericytes and resident fibroblasts to a myofibroblast lineage in SSc. Two pathways potentially contribute to the fibrogenic response in dcSSc. Microvascular pericytes (Thy-1+ve /α-SMA+ve ) become activated as a result of microvascular damage and produce the ED-A splice variant of fibronectin, a protein known to induce the myofibroblast phenotype. The microvascular derived ED-A FN in concert with the actions TGF-β may also act upon resident perivascular fibroblasts (Thy-1+ve /α-SMA-ve ) stimulating their differentiation to myofibroblasts. Proliferation of both pericytes and fibroblasts may help to create a pool of potential myofibroblasts. α-SMA, alpha smooth muscle actin; dcSSc, diffuse cutaneous systemic sclerosis; ED-A FN, ED-A splice variant of fibronectin; TGF-β, transforming growth factor-beta.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Jelaska A, Korn JH: Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum. 2000, 43: 2230-2239. 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8. · doi:10.1002/1529-0131(200010)43:10<2230::aid-anr10>3.0.co;2-8

Cited by

Items 201–240 of 240

Metadata

Authors
Rajkumar, V. S., Howell, K., Csiszar, K., Denton, C. P., Black, C. M., & Abraham, D. J.
Affiliations
The Royal Free Hospital (GB)
Corresponding author
Abraham, David J
Venue
Arthritis Research & Therapy
Published
2005-07-21
Volume
7
Issue
5
Pages
R1113-23
ISSN
1478-6354 (ISSN-L)
OpenAlex
W2138211373
Cited by
242
References
48
Citations by year
2026: 6 · 2025: 4 · 2024: 8 · 2023: 9 · 2022: 14 · 2021: 16 · 2020: 9 · 2019: 13 · 2018: 9 · 2017: 6 · 2016: 14 · 2015: 18 · 2014: 14 · 2013: 13 · 2012: 13
FWCI
7.04
Type
journal article
Language
en
Open access
Licence
Locations
  • Arthritis Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Rosetrees Trust
  • Jean Shanks Foundation
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (S11AR047713, AR47713)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
Keywords
diffuse cutaneous systemic sclerosis, myofibroblasts, pericytes, fibroblasts, skin fibrosis, microvascular damage, ED-A fibronectin, CD90, alpha-smooth muscle actin, proliferating cell nuclear antigen
MeSH terms
Actins, Adult, Aged, Collagen, Female, Fibroblasts, Fibronectins, Fibrosis, Humans, Male, Middle Aged, Phenotype, Scleroderma, Systemic, Skin, Biomarkers, Thy-1 Antigens, Proliferating Cell Nuclear Antigen, Cell Lineage, Pericytes, Myoblasts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.